|Articles|July 20, 2016
Mitsubishi Tanabe Joins Certara’s Simcyp Consortium
Certara announces the addition of Mitsubishi Tanabe to its Simcyp Consortium as the group’s 34th biopharmaceutical company.
Advertisement
Certara announces the addition of Mitsubishi Tanabe to its Simcyp Consortium as the group’s 34th biopharmaceutical company. Mitsubishi Tanabe has also licensed its proprietary Simcyp Population-based Simulator, which enables companies to study drug activity in virtual patients.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
3
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
4
Building Broader Investigator Networks to Advance Global Breast Cancer Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
